Locoregional Failure 10 Years After Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen Without Irradiation: Experience of the Eastern Cooperative Oncology Group
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
PURPOSE: To assess patterns of failure and how selected prognostic and treatment factors affect the risks of locoregional failure (LRF) after mastectomy in breast cancer patients with histologically involved axillary nodes treated with chemotherapy with or without tamoxifen without irradiation. PATIENTS AND METHODS: The study population consisted of 2,016 patients entered onto four randomized trials conducted by the Eastern Cooperative Oncology Group. The median follow-up time for patients without recurrence was 12.1 years (range, 0.07 to 19.1 years). RESULTS: A total of 1,099 patients (55%) experienced disease recurrence. The first sites of failure were as follows: isolated LRF, 254 (13%); LRF with simultaneous distant failure (DF), 166 (8%); and distant only, 679 (34%). The risk of LRF with or without simultaneous DF at 10 years was 12.9% in patients with one to three positive nodes and 28.7% for patients with four or more positive nodes. Multivariate analysis showed that increasing tumor size, increasing numbers of involved nodes, negative estrogen receptor protein status, and decreasing number of nodes examined were significant for increasing the rate of LRF with or without simultaneous DF. CONCLUSION: LRF after mastectomy is a substantial clinical problem, despite the use of chemotherapy with or without tamoxifen. Prospective randomized trials will be necessary to estimate accurately the potential disease-free and overall survival benefits of postmastectomy radiotherapy for patients in particular prognostic subgroups treated with presently used and future systemic therapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Self-citationThe Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Self-citationTamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332202 · Cited by 1,012
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables
Mehta, C. R., & Patel, N. R. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477989 · Cited by 898
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Peters, W. P., Ross, M., Vredenburgh, J. J., Meisenberg, B., Marks, L. B., Winer, E., Kurtzberg, J., Bast, R. C., Jones, R., & Shpall, E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1132 · Cited by 501
Fisher, B., Anderson, S., Wickerham, D. L., DeCillis, A., Dimitrov, N., Mamounas, E., Wolmark, N., Pugh, R., Atkins, J. N., Meyers, F. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1858 · Cited by 308
Improved methodology for analyzing local and distant recurrence.
Gelman, R., Gelber, R., Henderson, I. C., Coleman, C. N., & Harris, J. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.548 · Cited by 224
Fowble, B., Gray, R., Gilchrist, K., Goodman, R. L., Taylor, S., & Tormey, D. C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.7.1107 · Cited by 202
Self-citationFisher, B., Redmond, C. K., Wickerham, D. L., Bowman, D., Schipper, H., Wolmark, N., Sass, R., Fisher, E. R., Jochimsen, P. R., & Legault-Poisson, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.572 · Cited by 151
Goldhirsch, A., Gelber, R. D., & Castiglione, M. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.89 · Cited by 128
Analysis of the probability and risk of cause-specific failure
Caplan, R. J., Pajak, T. F., & Cox, J. D. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90416-2 · Cited by 99
Radical versus modified radical mastectomy for breast cancer.
Turner, L. M., Swindell, R., Bell, W. G., Hartley, R. C., Tasker, J. H., Wilson, W. W., Alderson, M., & Leck, I. M. (1981) · PubMed · Cited by 95
Boccardo, F., RUBAGOTTI, A., Bruzzi, P., Cappellini, M. D., Isola, G., Nenci, I., PIFFANELLI, A., Scanni, A., Sismondi, P., & Santi, L. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1310 · Cited by 94
Vélez-García, E., Carpenter, J. T., Moore, M., Vogel, C. L., Marcial, V. A., Ketcham, A. S., Singh, K. P., Bass, D., Bartolucci, A. A., & Smalley, R. V. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90015-t · Cited by 90
Hc, F., Gray, R. J., Wolberg, W. H., Gilchrist, K. W., Harris, J. E., Tormey, D. C., & Falkson, G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.4.599 · Cited by 71
Self-citationBoccardo, F., RUBAGOTTI, A., AMOROSO, D., Sismondi, P., Genta, F. T., Nenci, I., PIFFANELLI, A., Farris, A., CASTAGNETTA, L. A. M., Traina, A., et al. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80123-6 · Cited by 58
Kaufmann, M., Jonat, W., Abel, U. R., Hilfrich, J., Caffier, H., Kreienberg, R., Trams, G., Brunnert, K., Schermann, J., & Kleine, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.454 · Cited by 54
Taylor, S. G., Knuiman, M. W., Sleeper, L. A., Olson, J. E., Tormey, D. C., Gilchrist, K. W., Falkson, G., Rosenthal, S. N., Carbone, P. P., & Cummings, F. J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.879 · Cited by 52
Self-citationA note on estimating local recurrence rates in clinical trials on the treatment of breast cancer
Schulgen, G., Schmoor, C., Sauerbrei, W., & Schumacher, M. C. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005969923607 · Cited by 14
Cited by
Ragaz, J., Olivotto, I. A., Spinelli, J. J., Phillips, N., Jackson, S. M., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Weir, L., Gelmon, K., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh297 · Cited by 1,027
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1539 · Cited by 816
Self-citationMamounas, E. P., Anderson, S. J., Dignam, J. J., Bear, H. D., Julian, T. B., Geyer, C. E., Taghian, A., Wickerham, D. L., & Wolmark, N. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8369 · Cited by 587
Overview of Breast Cancer Therapy
Moo, T.-A., Sanford, R., Dang, C., & Morrow, M. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.006 · Cited by 551
Metadata
- Authors
- Recht, A., Gray, R., Davidson, N. E., Fowble, B. L., Solin, L. J., Cummings, F. J., Falkson, G., Falkson, H. C., Taylor, S. G., & Tormey, D. C.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-06
- Volume
- 17
- Issue
- 6
- Pages
- 1689-1689
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2130840692
- Cited by
- 440
- References
- 27
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.